Evaluation of three rapigen biocredit point-of-care tests for malaria case management in Lagos, Nigeria
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.19314 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Oluwagbemiga O Aina und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria. Hauptthemen laut MEDLINE: Sensitivity and Specificity, Malaria, Falciparum, Antigens, Protozoan, Reagent Kits, Diagnostic. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Histidine-rich protein 2 (HRP2) antigen kits are widely used for malaria diagnosis in tropical regions due to their heat stability. The Plasmodium Lactate Dehydrogenase (pLDH) used in BIOCREDIT® malaria test kit is claimed to be heat-stable. This study aimed to evaluate the heat stability and field performance of three BIOCREDIT® kits. Methodology: A cross-sectional community survey of malaria infection was carried out in Agbowa and Ikosi communities in Lagos State. Finger-prick blood was used to assess the performance of three BIOCREDIT® kits: Kit 1 (PfpLDH), Kit 2 (PfLDH/HRP2), and Kit 3 (PfLDH/PvLDH). Malaria microscopy and a reference mRDT (SD BIOLINE® PfHRP2) were used as comparators. Heat stability testing was performed using Plasmodium falciparum panels after exposure to 35oC and 45oC for 60 days. A total of 834 participants were recruited.
Results
The sensitivity of BIOCREDIT® kits were: Kit 1 (PfLDH) 88.4%; Kit 2 PfHRP2 92% and PfLDH 86.6%; Kit 3 (PfLDH) 88.4%. The specificity of kits was: Kit 1 (Pf LDH) 91.7%; Kit 2 (PfHRP2) 82.3%) and (PfLDH) 92.1%; Kit 3 (PfLDH) 91.6%. The sensitivity and specificity of the reference kit were 92.9% and 85.9%. The three BIOCREDIT® Kits were stable. No potential case of pfhrp2 gene deletion was observed.
Conclusions
The sensitivities of the three BIOCREDIT® malaria test kits were similar to the reference kit (SD BIOLINE mRDT). However, the specificities of PfLDH kits were significantly higher than the specificities of PfHRP2 kits. The BIOCREDIT® kits are suitable to be deployed in malaria-endemic tropical regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
- Department of Medical Laboratory Science, College of Medicine of University of Lagos, Idi-Araba, Lagos, Nigeria.
- National Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria.
- Aventis Pharmacy Ltd, Lokogoma, Abuja, Nigeria.
Zitieren
APA
Aina, O. O., Agomo, C. O., Ajibaye, O., Okoyenta, C. O., Ogbulafor, N., Ijezie, S., Orok, A. B., Oparaugo, C. T., Akindele, S. K., Bamgbose, D. J., Holdbrooke, S. A., Kareem, O. K., Olukosi, Y. A., & Ola, I. (2024). Evaluation of three rapigen biocredit point-of-care tests for malaria case management in Lagos, Nigeria. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.19314
Vancouver
Aina OO, Agomo CO, Ajibaye O, Okoyenta CO, Ogbulafor N, Ijezie S, et al. Evaluation of three rapigen biocredit point-of-care tests for malaria case management in Lagos, Nigeria. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.19314
BibTeX
@article{Aina2024,
author = {Aina, Oluwagbemiga O and Agomo, Chimere O and Ajibaye, Olusola and Okoyenta, Celestina O and Ogbulafor, Nnenna and Ijezie, Simon and Orok, Akwaowo B and Oparaugo, Chinedum T and Akindele, Samuel K and Bamgbose, Damilare J and Holdbrooke, Susan A and Kareem, Olaide K and Olukosi, Yetunde A and Ola, Isaac},
title = {Evaluation of three rapigen biocredit point-of-care tests for malaria case management in Lagos, Nigeria},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.19314}
}
EUVIMED